Use of Cortoss as an alternative material in calvarial defects: the first clinical results in cranioplasty

J Craniofac Surg. 2008 Jan;19(1):88-95. doi: 10.1097/scs.0b013e31815c93fe.

Abstract

A clinical series of 13 patients who underwent cranioplasty using a new quick setting material, namely Cortoss, was done over 3-year period. Thus, the primary objective of this study is to evaluate the role of Cortoss in the treatment calvarial defects which were mainly due to trauma (4 patients), tumor or tumor-like lesions (5 patients), middle cerebral infarction (3 patients), and gun shot wound (1 patient). The surgical technique was found to be simple and effective. Long-term follow-up (mean 24.3 months) demonstrated satisfactory results in terms of surgical (functional) and cosmetic outcomes. None of the patients developed complications including infections, foreign body reactions or material leakage. The results led us to suggest that the use of Cortoss in the case of calvarial defects seems to be safe, effective, quick, and a feasible method for cranioplasty. We conclude that the mechanical, immunologic, and technical-grafting properties of Cortoss, together with its superior esthetic and psychological effects, probably will make it the best material for cranioplasty.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Biocompatible Materials / therapeutic use*
  • Bisphenol A-Glycidyl Methacrylate / therapeutic use*
  • Bone Substitutes / therapeutic use*
  • Craniotomy / methods
  • Esthetics
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Infarction, Middle Cerebral Artery / surgery
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Plastic Surgery Procedures / methods*
  • Prospective Studies
  • Safety
  • Skull / injuries
  • Skull / surgery*
  • Skull Fractures / surgery
  • Skull Neoplasms / surgery
  • Treatment Outcome
  • Wounds, Gunshot / surgery

Substances

  • Biocompatible Materials
  • Bone Substitutes
  • CORTOSS
  • Bisphenol A-Glycidyl Methacrylate